Treatment with bofanglutide was associated with reductions in HbA1c levels, weight loss, and glycemic control among adults with T2DM.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results